Showing results (131-140 of 272) with videos related to
Sort By:
Pageof 28
AIDS (London, England)|January 13, 2017
Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial functionChristopher Schuster, Christina Binder, Robert Strassl, et al.Infection|November 28, 2025
Melioidosis imported to Northern Germany: a case report seriesDorothea Ekoka Mbassi, Aiman Gamal Abdelrahim, Ilka Grewe, et al.Wiener Klinische Wochenschrift|December 25, 2007
Increased prevalence of intestinal helminth infection during pregnancy in a Sub-Saharan African communityAyola A Adegnika, Selidji T Agnandji, Sanders K Chai, et al.Vaccine|September 20, 2012
Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situationHeimo Lagler, Selma Tobudic, Michael Ramharter, et al.Malaria Journal|March 20, 2026
Population pharmacokinetics of fosmidomycin and clindamycin in combination with artesunate for uncomplicated Plasmodium falciparum malaria in Gabonese children and adultsChristoph Pfaffendorf, Jean Claude Dejon-Agobé, Jean Ronald Edoa, et al.Frontiers in Immunology|September 28, 2020
Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of DiseaseMarissa Herrmann, Sophia Schulte, Nils H Wildner, et al.Malaria Journal|February 28, 2024
Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world studyMichael Ramharter, Abdoulaye A Djimde, Isabelle Borghini-Fuhrer, et al.Journal of Global Health|March 3, 2018
Behavioural and clinical predictors for LoiasisJohannes Mischlinger, Luzia Veletzky, Gildas B Tazemda-Kuitsouc, et al.Journal of Travel Medicine|April 25, 2023
Symptoms of illness during travel and risk factors for non-adherence to malaria prophylaxis-a cross-sectional study in travellers from GermanyFriederike Reinsberg, Mary W Moehlmann, Ralf Krumkamp, et al.Wellcome Open Research|August 30, 2024
The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeuticsJosephine Bourner, Alex Paddy Salam, Marie Jaspard, et al.Pageof 28